头颈游离皮瓣重建术后肺部并发症的发生率、发病率与死亡率:预测模型的局限性
回顾性分析638例头颈微血管游离皮瓣重建病例,2至5级术后肺部并发症发生率为27%,肿瘤分期、手术时长和血肿是其独立预测因素。住院死亡率为1.4%(n=9),且均发生5级肺部并发症。作者提出的模型(AUC 0.65)优于ARISCAT(AUC=0.51)和Gupta评分(AUC=0.45)。
要点
- 2至5级术后肺部并发症发生率为27%,住院死亡率为1.4%(n=9)。
- 多变量分析中肿瘤分期(OR 1.29)、手术时长(OR 1.08)和血肿(OR 2.98)为独立预测因素。
- 作者模型AUC 0.65,优于ARISCAT(AUC=0.51)和Gupta评分(AUC=0.45)。
核心结论
- 术后肺部并发症在头颈微血管游离皮瓣重建后常见,导致显著的发病率与死亡率。
- 现有预测模型不足,凸显了需要针对肿瘤性头颈外科的定制模型。
研究设计与样本
- 回顾性分析2019年8月至2024年5月638例头颈微血管游离皮瓣重建病例,数据通过病历回顾收集,聚焦术后30天内肺部并发症的术前、术中及术后危险因素。
- 研究地点为三级学术中心。
主要发现
- 2至5级术后肺部并发症发生于27%的患者。
- 单变量分析中,肺部并发症的预测因素包括手术时间延长(均值10.06±2.67小时,P=.006)、估计失血量≥200 mL(n=111,P=.006)、晚期肿瘤分期(III/IV期:n=123,P=.013)、血肿(n=25,P<.001)和术后输血(n=20,P=.037)。
- 多变量分析中,肿瘤分期(OR 1.29,95%CI 1.06-1.57,P=.012)、手术时长(OR 1.08,95%CI 1.01-1.17,P=.031)和血肿(OR 2.98,95%CI 1.50-5.94,P=.002)仍是2至5级肺部并发症的显著预测因素。
- 住院死亡率为1.4%(n=9),所有死亡患者均发生5级肺部并发症;1年死亡率为每100例患者13.48例,2至5级肺部并发症患者生存率显著更低(75.6% vs 89.4%)。
- 肺部并发症与死亡独立相关(HR 3.94,95%CI 1.69-9.22,P=.002);作者模型(AUC 0.65)在预测肺部并发症方面优于ARISCAT(AUC=0.51)和Gupta评分(AUC=0.45)。
临床怎么用
- 作者认为现有模型不充分,需要针对肿瘤性头颈外科的定制模型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Herein, we evaluate the incidence, risk factors, and prognostic implications of postoperative pulmonary complications (PPCs) in head and neck microvascular free flap (MVFF) reconstruction. Current prediction models were assessed, and a head and neck MVFF-specific model is proposed. STUDY DESIGN: Retrospective review of 638 head and neck MVFF cases from August 2019 to May 2024. SETTING: Tertiary academic center. METHODS: Data were collected via chart review focusing on preoperative, intraoperative, and postoperative risk factors for PPCs within 30 days of surgery. RESULTS: Grades 2 to 5 PPCs occurred in 27% of patients. Predictors of PPCs in univariate analysis include prolonged surgery (mean: 10.06 ± 2.67 hours, P = .006), estimated blood loss ≥ 200 mL (n = 111, P = .006), advanced tumor stage (III/IV: n = 123, P = .013), hematoma (n = 25, P < .001), and postoperative transfusion (n = 20, P = .037). Tumor stage (odds ratio [OR] 1.29, 95% CI 1.06-1.57, P = .012), surgery duration (OR 1.08, 95% CI 1.01-1.17, P = .031), and hematoma (OR 2.98, 95% CI 1.50-5.94, P = .002) remained significant predictors of grades 2 to 5 PPCs on multivariable analysis. In-hospital mortality was 1.4% (n = 9), and all experienced grade 5 PPCs. The 1-year mortality rate was 13.48 per 100 patients, with significantly lower survival in patients with grades 2 to 5 PPCs (75.6% vs 89.4%). PPC was independently associated with mortality (hazard ratio [HR] 3.94, 95% CI 1.69-9.22, P = .002). Our model (area under the curve [AUC] 0.65) outperformed the ARISCAT (AUC = 0.51) and Gupta scores (AUC = 0.45) in predicting PPCs. CONCLUSION: PPCs are common after MVFF, contributing to significant morbidity and mortality. Current models are inadequate, highlighting the need for a tailored model specific to oncologic head and neck surgery.
引用
- Abdul-Rahman NH, Harris MK, Bottegal M, et al. Incidence, Morbidity, and Mortality of Pulmonary Complications in Free Flap Reconstruction: Limitations of Predictive Models. Otolaryngol Head Neck Surg. 2025. PMID: 40407209. doi:10.1002/ohn.1304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。